Zimbabwe Health News API

{
    "totalArticles": 578,
    "articles": [
        {
            "id": "298f36fc42e58a98c6fe36ce8aca5c95",
            "title": "5 Pulmonology Headlines You Missed in November 2025",
            "description": "November 2025 saw new data on asthma therapies and new insights from experts on continuing trends in the field.",
            "content": "November delivered a wave of advances across asthma, COPD, and related inflammatory airway diseases, reflecting the accelerating shift toward precision medicine in respiratory care. New data showed pulmonary rehabilitation’s unexpected anti-inflammat... [3849 chars]",
            "url": "https://www.hcplive.com/view/5-pulmonology-headlines-you-missed-november-2025",
            "image": "https://cdn.sanity.io/images/0vv8moc6/hcplive/2724e4becaac7f21bb50f06619665ac27e6b83b3-1200x630.jpg",
            "publishedAt": "2025-12-03T22:01:26Z",
            "lang": "en",
            "source": {
                "id": "fdb44255685fc0ff4da1d8b3d77003bf",
                "name": "HCPLive",
                "url": "https://www.hcplive.com"
            }
        },
        {
            "id": "438a2845dae292b3d01b8b184bc8fc2c",
            "title": "Biomarker studies to predict outcomes of patients with COVID-19 related acute respiratory distress syndrome measured pre and post initiation of veno venous extracorporeal membrane oxygenation",
            "description": "Veno-venous extracorporeal membrane oxygenation (V-V ECMO) is a resource intensive and expensive therapy increasingly used to treat a select group of patients with severe acute respiratory distress syndrome (ARDS). High levels of Interleukin-10 (IL-10) are reported to be predictive of mortality in non-COVID ARDS patients receiving ECMO. In this study we evaluated if levels of biomarkers including IL-10 can predict mortality if measured prior to ECMO initiation in patients with COVID-19 ARDS. A total of sixteen patients with COVID-related ARDS undergoing treatment with ECMO were included in the pre-ECMO biomarker analysis, while samples from a total of 22 patients with post-ECMO samples were analyzed. Nine of sixteen patients with pre-ECMO samples (56%) survived to hospital discharge. There was no difference in baseline demographics between survivors and non-survivors. In univariate analysis, survivors had no difference in IL-10 levels prior to ECMO initiation although we identified several other biomarkers (Ang 1 and TNF-alpha with logistical regression, Mitochondrial DNA and IP-10 with Kaplan–Meier analysis) that differed significantly between survivors and non-survivors. Moreover, as opposed to a prior study, area under the curve (AUC) analysis showed that IL-10 levels were not predictive of survival. We advise caution for utilizing a single biomarker as outcome predictor in this highly complex population with often long clinical courses despite our promising results.",
            "content": "Veno-venous extracorporeal membrane oxygenation (V-V ECMO) is a resource intensive and expensive therapy increasingly used to treat a select group of patients with severe acute respiratory distress syndrome (ARDS). High levels of Interleukin-10 (IL-1... [2143 chars]",
            "url": "https://www.nature.com/articles/s41598-025-30047-9?error=cookies_not_supported&code=e2b789cf-28d6-4cdc-b3b8-add172eb2a8a",
            "image": "https://www.nature.com/static/images/favicons/nature/favicon-48x48-b52890008c.png",
            "publishedAt": "2025-12-03T21:58:27Z",
            "lang": "en",
            "source": {
                "id": "7abf0df285fbe93cdccffcc7c4088737",
                "name": "Nature",
                "url": "https://www.nature.com"
            }
        },
        {
            "id": "f636dd13b75f2aef36d94ee8e8a116ab",
            "title": "Prostate cancer screening rejected by UK government advisers - here’s why",
            "description": "A roster of high profile advocates, including sportsmen, actors, two previous prime ministers and over 100 MPs, have recently joined patient groups and charities in calling for a UK national prostate cancer screening program. However, the UK National Screening Committee (UKNSC) has announced its draft decision to advise the government against routine…",
            "content": "A roster of high profile advocates, including sportsmen, actors, two previous prime ministers and over 100 MPs, have recently joined patient groups and charities in calling for a UK national prostate cancer screening program.\nHowever, the UK National... [4281 chars]",
            "url": "https://japantoday.com/category/features/health/prostate-cancer-screening-rejected-by-uk-government-advisers-%E2%80%93-here%E2%80%99s-why",
            "image": "https://media.japantoday.com/img/store/dd/8a/17e35313c2fdb3e53043d97ada3d50b1970c/istock-1376569576/_w1700.jpeg",
            "publishedAt": "2025-12-03T20:20:00Z",
            "lang": "en",
            "source": {
                "id": "b6e16e937954be66de0f0475c3640971",
                "name": "Japan Today",
                "url": "https://japantoday.com"
            }
        }
    ]
}